Try our Advanced Search for more refined results

In re: Lipitor Antitrust Lit

  1. July 08, 2015

    Antitrust Cases To Watch In The 2nd Half Of 2015

    The first half of 2015 was action-packed with rulings on key pharmaceutical antitrust issues and agency wins in high-profile challenges, but there's still plenty to watch for over the next six months, including cases that could alter the landscape of college sports and professional baseball and major challenges to benchmark banking rates.

  2. April 22, 2015

    Retailers Slam Pushback To Linking Effexor, Lipitor Appeals

    Rite Aid Corp., Walgreen Co. and others on Wednesday reinforced their push to consolidate pending appeals in the Lipitor and Effexor XL pay-for-delay suits, arguing that a single Third Circuit panel review is the fairest, most economical approach.

  3. April 17, 2015

    Drug Cos. Rip Bid To Merge Lipitor, Effexor Antitrust Appeals

    Pfizer Inc. and Ranbaxy Inc. on Thursday urged the Third Circuit to reject a bid by Rite Aid Corp., Walgreen Co. and other retailers to consolidate all pending appeals in the Lipitor and Effexor XP pay-for-delay litigations, saying the cases are far too different to consolidate.

  4. April 03, 2015

    3rd Circ. Urged To Merge Lipitor, Effexor Antitrust Appeals

    Rite Aid Corp., Walgreen Co. and other retailers asked the Third Circuit on Friday to consolidate all pending appeals in the Effexor XR and Lipitor pay-for-delay litigations, saying it would conserve resources given the similarities in the legal issues raised and overlap of parties and counsel.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!